Our Pricing

Understanding the Sulphur Burps on Mounjaro Timeline: Week-by-Week Guide

Published on: June 03, 2026

If you're researching the sulphur burps on mounjaro timeline, you're not alone—this distinctive side effect affects many patients starting tirzepatide treatment in the UK. At Cured Pharmacy, our clinical team has supported thousands of patients through their weight loss journey, and we understand exactly when sulphur burps typically emerge, peak, and resolve during your Mounjaro treatment.

Why Does Mounjaro Cause Sulphur Burps?

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that significantly slows gastric emptying—the rate at which food moves from your stomach into your small intestine [1]. This delayed emptying is part of how the medication works to reduce appetite and promote weight loss, but it also creates an environment where food remains in the digestive tract longer than usual.

When partially digested food sits in your stomach and upper intestine for extended periods, bacterial fermentation increases, producing hydrogen sulphide gas. This gas creates the characteristic rotten egg smell and taste associated with sulphur burps [2]. The effect is more pronounced during dose escalation phases when your body is still adapting to the medication's impact on your digestive system.

Clinical data from the SURPASS trials showed gastrointestinal side effects—including eructation (belching) and dyspepsia—were most common during the initial 12 weeks of treatment, with incidence decreasing as patients adapted to their maintenance dose [1].

Weeks 1-4: Initial Dose Period (2.5mg)

During your first month on the starting dose of 2.5mg, sulphur burps are relatively uncommon but can occur in approximately 10-15% of patients. Your body is beginning to adjust to tirzepatide's effects on gastric motility, and most patients experience mild digestive changes rather than pronounced symptoms.

When sulphur burps do appear in this early phase, they're typically sporadic—occurring once or twice weekly rather than daily. Many patients report they're more noticeable after consuming fatty, protein-rich, or cruciferous foods that naturally produce more sulphur compounds during digestion.

Our superintendent pharmacist Tarun Kumar advises that this initial period is crucial for establishing dietary habits that minimise gastrointestinal side effects throughout your treatment journey. Smaller, more frequent meals and avoiding trigger foods can significantly reduce early symptoms.

What to Expect in Your First Injection

Most patients tolerate their first 2.5mg injection well, with nausea being more common than sulphur burps initially. If you do experience sulphur burps in week one, they typically resolve within 48-72 hours as your body begins adapting to the medication. Staying well-hydrated and avoiding large meals immediately after your weekly injection can help minimise symptoms.

Weeks 5-8: First Dose Increase (5mg)

The transition to 5mg at week five represents the most common period for sulphur burps to emerge or intensify. Clinical experience shows this is when approximately 25-30% of patients report experiencing this side effect, as the increased dose amplifies gastric emptying delay.

During weeks 5-8, sulphur burps may occur daily for some patients, particularly in the 24-48 hours following your weekly injection when tirzepatide plasma concentrations are highest. The burps are often accompanied by mild bloating, a feeling of fullness, and occasionally mild nausea [2].

This phase is temporary for most patients. Your digestive system is recalibrating to the stronger GLP-1 and GIP receptor activation, and symptoms typically begin improving by week 7-8 as your body establishes a new baseline. Approximately 60-70% of patients who experience sulphur burps during this period report significant improvement before their next dose increase.

Managing Peak Symptom Period

If sulphur burps are troublesome during the 5mg phase, consider spacing your meals 4-5 hours apart, reducing dietary fat to under 30% of calories, and avoiding carbonated beverages. Some patients find that taking a probiotic supplement helps rebalance gut bacteria, though evidence for this approach is anecdotal rather than clinical.

Weeks 9-16: Escalation to 7.5mg and 10mg

As you progress through the 7.5mg dose (weeks 9-12) and potentially to 10mg (weeks 13-16), the pattern of sulphur burps often differs from the 5mg transition. Interestingly, many patients report that symptoms plateau or even improve during this phase, despite the higher dose.

This improvement occurs because your body has had 8-12 weeks to adapt to tirzepatide's mechanism of action. Gastric accommodation—your stomach's ability to relax and adjust to its new emptying rate—improves over time. Additionally, most patients have identified and eliminated their dietary triggers by this stage [1].

However, approximately 15-20% of patients do experience a resurgence of sulphur burps when moving to 10mg, particularly if this transition happens quickly. The MHRA-approved dosing schedule allows for flexibility, and your UK prescriber may recommend staying at 7.5mg for an additional four weeks if side effects are limiting your quality of life.

Weeks 17+: Maintenance Doses (12.5mg and 15mg)

By the time patients reach maintenance doses of 12.5mg or 15mg, sulphur burps have typically resolved or become significantly less frequent. Clinical data suggests that fewer than 10% of patients on long-term Mounjaro treatment continue experiencing regular sulphur burps beyond week 20 [1].

For the minority who do have persistent symptoms, they're usually manageable with dietary modifications and rarely severe enough to warrant discontinuation. The body's adaptation to chronic GLP-1/GIP receptor stimulation means that gastric emptying, while still slower than baseline, becomes more predictable and less prone to causing fermentation-related symptoms.

At Cured Pharmacy, we provide ongoing support throughout your treatment journey. If sulphur burps persist beyond the first four months or significantly impact your daily life, our clinical team can arrange a medication review to explore strategies including temporary dose reduction, dietary consultation, or consideration of alternative weight loss treatments.

Long-Term Outlook

Research from extended SURPASS trial data shows that gastrointestinal tolerability continues to improve beyond six months of treatment. Patients who persist through the initial adjustment period typically achieve excellent weight loss outcomes—averaging 15-22.5% body weight reduction depending on final dose—with minimal ongoing side effects [1].

Practical Strategies to Reduce Sulphur Burps on Mounjaro

Dietary modification remains the most effective non-pharmacological approach to managing sulphur burps. Reducing intake of high-sulphur foods—including eggs, red meat, cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), garlic, and onions—can significantly decrease symptom frequency. Many patients find keeping a food diary for the first 12 weeks helps identify their specific triggers.

Eating smaller, more frequent meals (5-6 per day rather than 3 large meals) works with Mounjaro's mechanism rather than against it. Since the medication slows gastric emptying, smaller volumes of food move through your system more efficiently, reducing the bacterial fermentation that produces hydrogen sulphide gas [2].

Staying well-hydrated is crucial—aim for 2-3 litres of water daily. Adequate hydration supports digestive motility and helps dilute stomach contents, making them less prone to fermentation. Some patients report that ginger tea or peppermint tea between meals provides additional symptom relief, though clinical evidence for these remedies is limited.

If lifestyle measures aren't sufficient, speak with your prescriber about short-term use of simethicone (an over-the-counter anti-foaming agent) or bismuth subsalicylate, which can reduce gas production and neutralise hydrogen sulphide. These are available without prescription but should be discussed with your clinical team to ensure they don't interfere with Mounjaro's absorption or efficacy.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
4. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
5. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro (tirzepatide) is a prescription-only medicine in the UK and must be prescribed following an online consultation with our clinical team.